BRPI0815821A2 - Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico. - Google Patents

Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico.

Info

Publication number: BRPI0815821A2
Authority: BR; Brazil
Prior art keywords: anesthetics; compositions; achieve; methods; saving effect
Prior art date: 2007-08-27

Application number

BRPI0815821-5A2A

Other languages

English (en)

Inventor

Cecil Mark Eppler

William W Muir Iii

David Robert Hustead

Thomas Gerard Cullen

Raphael Johannes Gerhardus Zwijnenberg

Original Assignee

Wyeth Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-27

Filing date

2008-08-26

Publication date

2015-02-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39797439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0815821(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-08-26 Application filed by Wyeth Llc filed Critical Wyeth Llc

2015-02-18 Publication of BRPI0815821A2 publication Critical patent/BRPI0815821A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Anesthesiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0815821-5A2A 2007-08-27 2008-08-26 Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico. BRPI0815821A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US96823607P	2007-08-27	2007-08-27
PCT/US2008/074317 WO2009029618A1 (en)	2007-08-27	2008-08-26	Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect

Publications (1)

Publication Number	Publication Date
BRPI0815821A2 true BRPI0815821A2 (pt)	2015-02-18

Family

ID=39797439

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0815821-5A2A BRPI0815821A2 (pt)	2007-08-27	2008-08-26	Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico.

Country Status (14)

Country	Link
US (1)	US20090061024A1 (pt)
EP (1)	EP2195031A1 (pt)
JP (1)	JP2010537999A (pt)
KR (1)	KR20100049663A (pt)
CN (1)	CN101896205A (pt)
AR (1)	AR068350A1 (pt)
AU (1)	AU2008293622A1 (pt)
BR (1)	BRPI0815821A2 (pt)
CA (1)	CA2697739A1 (pt)
CL (1)	CL2008002523A1 (pt)
MX (1)	MX2010002191A (pt)
TW (1)	TW200918077A (pt)
WO (1)	WO2009029618A1 (pt)
ZA (1)	ZA201001252B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2010226479A1 (en)	2009-03-19	2011-09-22	Wyeth Llc	Methods for the preparation of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7) -en-2-yl)ethyl]phosphonic acid and precursors thereof
US11083696B2 (en) *	2011-09-21	2021-08-10	University College Cardiff Consultants Limited	Dispersion anaesthetic device
KR20150036535A (ko)	2012-07-10	2015-04-07	더 리젠츠 오브 더 유니버시티 오브 캘리포니아	마취를 유도하는 방법
FR2998892B1 (fr)	2012-12-04	2015-01-02	Pf Medicament	Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments
WO2015149066A1 (en) *	2014-03-28	2015-10-01	University Of Virginia Patent Foundation	General anesthetics that are not neurotoxic
WO2015187918A2 (en)	2014-06-05	2015-12-10	The Regents Of The University Of California	Halogenated ether compounds and methods of inducing anesthesia
FR3022456B1 (fr) *	2014-06-20	2016-07-15	Air Liquide	Xenon associe a un antagoniste des recepteurs nmda pour lutter contre une proliferation tumorale dans le systeme nerveux central
US20200297734A1 (en)	2015-06-19	2020-09-24	Melt Pharmaceuticals, Inc.	Pharmaceutical compositions and methods for anesthesiological applications
US10391102B2 (en) *	2015-06-19	2019-08-27	Melt Pharmaceuticals, Inc.	Pharmaceutical compositions and methods for anesthesiological applications
US10555952B2 (en)	2015-06-19	2020-02-11	Melt Pharmaceuticals, Inc.	Pharmaceutical compositions and methods for anesthesiological applications
CN106176770A (zh) *	2016-07-11	2016-12-07	孙剑	一种男性发育期注射麻醉剂
CN106109468A (zh) *	2016-07-11	2016-11-16	孙剑	一种女性发育期注射麻醉剂
CN106166159A (zh) *	2016-07-11	2016-11-30	孙剑	一种复方注射麻醉剂
CN109794292B (zh) *	2019-01-10	2021-12-07	天津大学	Z-选择性钌卡宾烯烃复分解催化剂及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5168103A (en) *	1991-01-22	1992-12-01	American Home Products Corporation	[[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives
US5124319A (en) *	1991-10-11	1992-06-23	American Home Products Corporation	Benzimidazole phosphono-amino acids
US5990307A (en) *	1997-08-01	1999-11-23	American Home Products Corporation	Process for the preparation of [2-((8.9)-Dioxo-2,6-Diazabicyclo [5.2.0]-Non-1(7)-en-2yl) Ethyl]Phosphonic acid
US6225343B1 (en) *	1999-06-16	2001-05-01	Nastech Pharmaceutical Company, Inc.	Compositions and methods comprising morphine gluconate
US7089200B2 (en) *	1999-12-21	2006-08-08	Third Millennium Management Pty Ltd	Payroll management method and apparatus
UA78529C2 (en) *	2001-10-10	2007-04-10	Wyeth Corp	Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain
US20040082543A1 (en) *	2002-10-29	2004-04-29	Pharmacia Corporation	Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
CN1802161A (zh) *	2003-04-09	2006-07-12	惠氏公司	[2－(8,9－二氧代－2,6－二氮杂双环[5.2.0]壬－1(7)－烯－2－基)烷基]－膦酸及其衍生物的鼻内给药药用组合物及用法
ATE481103T1 (de) *	2003-04-09	2010-10-15	Wyeth Llc	Derivate von 2-(8,9-dioxo-2,6- diazabicyclo(5.2.0)non-1(7)-en-2- yl)alkylphosphonsäure und deren verwendung als n- methyl-d-aspartat- (nmda-) rezeptorantagonisten
US20050142192A1 (en) *	2003-10-15	2005-06-30	Wyeth	Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives
EP1797104B1 (en) *	2004-10-08	2009-11-25	Wyeth	Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and method of making them

2008
- 2008-08-26 AU AU2008293622A patent/AU2008293622A1/en not_active Abandoned
- 2008-08-26 JP JP2010523089A patent/JP2010537999A/ja not_active Withdrawn
- 2008-08-26 CN CN2008801134468A patent/CN101896205A/zh active Pending
- 2008-08-26 BR BRPI0815821-5A2A patent/BRPI0815821A2/pt not_active IP Right Cessation
- 2008-08-26 CA CA2697739A patent/CA2697739A1/en not_active Abandoned
- 2008-08-26 MX MX2010002191A patent/MX2010002191A/es not_active Application Discontinuation
- 2008-08-26 WO PCT/US2008/074317 patent/WO2009029618A1/en not_active Ceased
- 2008-08-26 US US12/198,489 patent/US20090061024A1/en not_active Abandoned
- 2008-08-26 EP EP08828330A patent/EP2195031A1/en not_active Withdrawn
- 2008-08-26 KR KR1020107006600A patent/KR20100049663A/ko not_active Ceased
- 2008-08-27 AR ARP080103731A patent/AR068350A1/es not_active Application Discontinuation
- 2008-08-27 CL CL200802523A patent/CL2008002523A1/es unknown
- 2008-08-27 TW TW097132752A patent/TW200918077A/zh unknown
2010
- 2010-02-22 ZA ZA2010/01252A patent/ZA201001252B/en unknown

Also Published As

Publication number	Publication date
US20090061024A1 (en)	2009-03-05
CA2697739A1 (en)	2009-03-05
WO2009029618A1 (en)	2009-03-05
JP2010537999A (ja)	2010-12-09
KR20100049663A (ko)	2010-05-12
CN101896205A (zh)	2010-11-24
TW200918077A (en)	2009-05-01
EP2195031A1 (en)	2010-06-16
MX2010002191A (es)	2010-03-17
CL2008002523A1 (es)	2008-10-10
AR068350A1 (es)	2009-11-11
AU2008293622A1 (en)	2009-03-05
ZA201001252B (en)	2011-04-28

Publication	Publication Date	Title
BRPI0815821A2 (pt)	2015-02-18	Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico.
BRPI0815407A2 (pt)	2014-09-30	Composições e métodos para controlar nematódeos
BRPI0908792A2 (pt)	2015-07-21	Composição, e, uso de uma combinação
BRPI0919193A2 (pt)	2015-08-18	Uso de lipídeo, e, composição nutricional
BRPI0919466A2 (pt)	2015-12-01	composição farmacêutica para liberação modificada
HRP20180718T1 (hr)	2018-07-13	Oligopeptidni spojevi i njihova upotreba
NO20090079L (no)	2009-02-16	Arylsulfonamider med analgesisk virkning
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
PL2356462T3 (pl)	2017-07-31	Kompozycje anty-CXCR1 oraz sposoby
BRPI1013421A2 (pt)	2016-04-05	composição parasticida tópica, e, uso de uma composição
CL2008002041A1 (es)	2009-01-09	Compuestos derivados de piperidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar ansiedad.
ES2397671T8 (es)	2013-05-23	Procedimiento para preparar voriconazol
EP2037872A4 (en)	2012-10-10	COMPOSITIONS COMPRISING BITULONIC ACID
BRPI0813770A2 (pt)	2014-12-30	Composição, e, uso de uma composição
IT1392101B1 (it)	2012-02-09	Composizione comprendente isoflavoni
EP2374452A4 (en)	2015-03-25	NUTRIENT COMPOSITION
BRPI0914793A2 (pt)	2015-08-04	Composição, e, uso de uma composição
BRPI0909885A2 (pt)	2015-10-27	composição decorativa e método para sua utilização
EP2236149A4 (en)	2012-12-26	MEDICAL COMPOSITION
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
BRPI0822472A2 (pt)	2015-06-16	Método, camundongo, e, composição
BRPI0913136A2 (pt)	2016-01-05	método para produzir uma peça e peça.
BRPI0722183A2 (pt)	2015-06-16	Composições farmacêuticas para tratar depressão e ansiedade
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 6A E 7A ANUIDADES.
2016-03-29	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.